Postoperative Delirium in Cardiac Surgery ICU

August 23, 2020 updated by: Shanghai Zhongshan Hospital

Study on Visual Assessment System and Stratified Management Program for Postoperative Delirium After Cardiac Surgery

Postoperative Delirium (POD) is a common complication in patients after cardiac surgery, which is associated with short-term prognosis and long-term quality of life. Due to the lack of specific treatment, prevention is the most effective strategy to reduce delirium. Risk assessment greatly contributes to guide prevention by stratifying the risk of the POD. However, the high-quality risk assessment tools are still sparse, and the combination of risk assessment and stratified prevention has not been applied to the management of delirium after cardiac surgery. In the previous work, we found the predictive value of preoperative cardiac function on POD, and found a critical value. On the basis of previous research, this project will learn from previous studies on risk factors of POD, and deeply explore potential predictors. Furthermore, we will develop and validate POD risk prediction model, and then develop it into a visual evaluation system. In addition, based on the theory of risk management and risk assessment tools, using the concepts and methods of evidence-based medicine, the risk assessment system and stratified management program of POD will be formed and evaluated by expert discussion meetings. It is expected that the risk assessment system and stratified management program constructed by this project could simply and quickly screen high-risk patients and carry out timely intervention, so as to reduce the incidence of POD, improve patients' prognosis and the quality of life after cardiac surgery.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

500

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients aged above 18 who are admitted to surgical ICUs after cardiac surgery will be screened for eligibility.

Description

Inclusion Criteria:

  • Aged above 18
  • Patients after cardiac surgery
  • Admitted to ICU after surgery

Exclusion Criteria:

  • Preoperative delirium or dementia patients
  • Unable to fully participate in delirium testing, including blind, deaf, illiterate or inability to understand Chinese
  • Undergoing surgery procedures do not require admission to SICU
  • Transfer to ICU from wards after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
cardiac surgery patients in ICU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative delirium
Time Frame: up to 5 days postoperatively
Investigators defined patients have delirium if they had at least one positive screening during ICU stay.
up to 5 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of postoperative delirium
Time Frame: up to 5 days postoperatively
Assess by CAM-ICU-7 if CAM-ICU is positive. Categorized as no delirium: 0-2, mild to moderate delirium: 3-5, and severe delirium: 6-7
up to 5 days postoperatively
duration of postoperative delirium
Time Frame: up to 5 days postoperatively
Defined as time (in days) from the first positive CAM-ICU until the beginning of two consecutive days of negative CAM-ICU.
up to 5 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2021

Primary Completion (Anticipated)

March 1, 2022

Study Completion (Anticipated)

September 30, 2022

Study Registration Dates

First Submitted

August 23, 2020

First Submitted That Met QC Criteria

August 23, 2020

First Posted (Actual)

August 26, 2020

Study Record Updates

Last Update Posted (Actual)

August 26, 2020

Last Update Submitted That Met QC Criteria

August 23, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

3
Subscribe